Golimumab Interactions
There are 487 drugs known to interact with golimumab, along with 7 disease interactions. Of the total drug interactions, 290 are major, 190 are moderate, and7 are minor.
- View all 487 medications that may interact with golimumab
- View golimumab disease interactions (7)
Most frequently checked interactions
View interaction reports for golimumab and the medicines listed below.
- Aleve (naproxen)
- Amitiza (lubiprostone)
- Armour Thyroid (thyroid desiccated)
- Aspir 81 (aspirin)
- Botox (onabotulinumtoxinA)
- Celebrex (celecoxib)
- Citracal Maximum (calcium / vitamin d)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Copper (copper gluconate)
- Cosentyx (secukinumab)
- Cymbalta (duloxetine)
- Drysol (aluminum chloride hexahydrate topical)
- Enbrel (etanercept)
- Estrace (estradiol)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Glucosamine & Chondroitin with MSM (chondroitin / glucosamine / methylsulfonylmethane)
- Glycerol (glycerin)
- Humira (adalimumab)
- Iron Sulfate (ferrous sulfate)
- Methotrexate LPF Sodium (methotrexate)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Paracetamol (acetaminophen)
- Plaquenil (hydroxychloroquine)
- Quercetin (bioflavonoids)
- Synthroid (levothyroxine)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Golimumab disease interactions
There are 7 disease interactions with golimumab which include:
More about golimumab
- golimumab consumer information
- Compare alternatives
- Reviews (153)
- Side effects
- Dosage information
- During pregnancy
- Drug class: TNF alfa inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.